@ARTICLE{
author={Stupp Roger,...,Grujicic Danica M,...,(broj koautora 37)},
year={2014},
title={Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial},
journal={LANCET ONCOLOGY},
volume={15},
number={10},
pages={1100-1108},
document_type={Article},
} 

@ARTICLE{
author={Stupp Roger,...,Grujicic Danica M,...,(broj koautora 20)},
year={2013},
title={Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma and methylated O-6-methylguanine-DNA methyltransferase (MGMT) gene promoter: Key results of the multicenter, randomized, open-label, controlled, phase III CENTRIC study.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={31},
number={18},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Stupp Roger,...,Grujicic Danica M,...,(broj koautora 20)},
year={2013},
title={Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with O-6-methylguanine-DNA methyltransferase (MGMT) promoter methylation: Final results of the multicenter, randomized, open-label, controlled, phase III CENTRIC study.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={31},
number={15},
pages={-},
document_type={Meeting Abstract},
}